Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.815643
Title: A comparison study of health benefits and cost savings of diabetes medications used to treat type II diabetes in the State of Georgia, United States of America
Author: Henderson, Sonja
ISNI:       0000 0004 9358 6986
Awarding Body: University of Liverpool
Current Institution: University of Liverpool
Date of Award: 2020
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Actionable research, at a doctoral level, allows personnel to utilize personal experiences within the organization to explore the possibility to manifest change through collaborative efforts of internal and external stakeholders within the industry (Coghlan and Brannick, 2010). Background: The practice-based problem for this actionable research is as follows: In the United States, branded medications used to treat type II diabetes are more expensive than generic medications. The literature lacks sufficient evidence to support the healthcare provider's decision to order a more expensive product to treat this chronic disease, type II diabetes as opposed to a less expensive product. Aim / Objectives: The process of action learning addressed the aim and objectives for this study. To begin with, the survey conducted in this study was to address the prevalence and impact of type II diabetes in the state of Georgia, USA via uncovering the direct and indirect costs associated with this chronic disease. Using this demographical and geographical diverse population in the state of Georgia, inferences about the health benefits and cost-savings of diabetes medications used to treat type II diabetes created the aim of the study by properly characterizing the type II diabetes population in Georgia. The objective of the study was to utilize the actionable knowledge gained from the study to create a data-driven document that can be executed in the decision making process of treating type II diabetes. This actionable knowledge led to the creation of a new document which involves the decision-making process of the healthcare professional. This document allows the rationality of integrating factors that are associated with the standards of care when choosing a medication to treat type II diabetes such as efficacy and safety ~ instead of simply the cost of the medication at the pharmacy counter. Methodology: The impact of type II diabetes on the state of Georgia was determined by using a patientcentered approach. Upon gathering data, the process of micro-costing was implemented to estimate the cost of treatment(s) and complications related to type II diabetes. Generic and brand name medication pricing were determined by referencing GoodRx.com and Cost Helpers, Inc. An analysis of variance was obtained using inferential and descriptive statistics to compute the direct and indirect costs associated with the treatment of type II diabetes. Results: Upon completion of the comparison of health benefits and cost savings of diabetes medications used to treat type II diabetes in the state of Georgia, USA, the results were not statistically significant. However, the literature review revealed a number of studies that not only resulted in a statistical significance but a clinical significance as well (Saydah et al, 2004; Carnethon et al, 2010; Loeppke et al, 2009; Fitch et al., 2017 ). In fact, this action learning research revealed the health benefits of the branded medications outweighed the health benefits of the generic medications. The patient-reported data of less complications and hospitalizations was associated with the branded, more expensive products. This is important because a reduction in diabetesrelated complications results in an overall reduction in the cost to treat type II diabetes in the United States (Fitch et al., 2017). Conclusions: The two theoretical frameworks used for this study included the following: Choo's Knowing Organization was the foundation used to enhance the knowledge of this writer regarding the prevalence and impact of type II diabetes on the state of Georgia, USA. The completion of the study created actionable knowledge, a depiction of direct and indirect costs associated with type II diabetes. The itemization of these costs indicated that cardiovascular related complications were responsible for the majority of the expenses related to type II diabetes. Simon's Bounded Theory of Rationality was the foundation used to create a modified version of a Pay for Performance model. This model was used to create a document to address the long-term complications associated with type II diabetes, namely cardiovascular related complications. The implementation of this tool creates a clinically justifiable reason to prescribe a product for the type II diabetes. This rationale is based on efficacy and safety ~ not simply the nominal cost of the medication. The underlying concept of this tool is to strengthen the accountability efforts of the pharmaceutical company to produce value-based results for those patients adhering to the prescribed regimen.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (D.B.A.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.815643  DOI:
Share: